Who invested in Secretome Therapeutics?
Secretome Therapeutics's investors include RA Capital Management and TEDCO. RA Capital Management led its latest round.

United States · Series A startup
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 6 months ago
Follow Secretome Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$50Mraised across 2 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Secretome Therapeutics filed one raise, $6.9M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 1 on the team.
On the board, as filediAngela ShenHenrik RasmussenSunjay KaushalWilliam Niland
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Secretome Therapeutics's investors include RA Capital Management and TEDCO. RA Capital Management led its latest round.
Secretome Therapeutics has raised $50M across 2 rounds since 2024.
Secretome Therapeutics's most recent round was a Series A of $30M in May 2026, led by RA Capital Management.
Its most recent round, $30M in May 2026, is also its largest on record.
Secretome Therapeutics's first round on record, in May 2026, was backed by RA Capital Management and TEDCO.
Secretome Therapeutics's latest named round is a Series A, in May 2026.
Secretome Therapeutics is based in the United States.
RA Capital Management led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.